about
Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients--a simulation study.Three independent mutations in the TSC2 gene in a family with tuberous sclerosis.Imputation by the mean score should be avoided when validating a Patient Reported Outcomes questionnaire by a Rasch model in presence of informative missing dataBiases and power for groups comparison on subjective health measurements.Spatio-temporal Rasch analysis of quality of life outcomes in the French general population: measurement invariance and group comparisonsPower and sample size determination for the group comparison of patient-reported outcomes with Rasch family models.Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Risk factors for antibiotic-associated diarrhea.Comparison of CTT and Rasch-based approaches for the analysis of longitudinal Patient Reported Outcomes.The challenge of measuring quality of life in children with Hirschsprung's disease or anorectal malformation.The influence of gait speed on co-activation in unilateral spastic cerebral palsy children.Towards power and sample size calculations for the comparison of two groups of patients with item response theory models.Power and sample size determination for group comparison of patient-reported outcomes using polytomous Rasch models.Quality of life and coping of women treated for breast cancer and their caregiver. What are the interactions?Glioplasticity in irritable bowel syndrome.A shorter and multidimensional version of the Gambling Attitudes and Beliefs Survey (GABS-23).Illness-related stigma, mood and adjustment to illness in persons with hepatitis C.Exploring how students think: a new method combining think-aloud and concept mapping protocols.Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis.Can we say that seniors are addicted to benzodiazepines?Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli.Base excess is an accurate predictor of elevated lactate in ED septic patientsAssessment of adverse drug event recognition by emergency physicians in a French teaching hospitalStress responses in medical students in ambulatory and in-hospital patient consultationsEffect of stress on clinical reasoning during simulated ambulatory consultationsHow do doctors perceive and use patient quality of life? Findings from focus group interviews with hospital doctors and general practitioners
P50
Q33546139-39513D34-3A05-4480-9707-21595026A515Q33869969-B75CACA2-D0D9-412D-A17B-BF0947F03078Q33960759-53A475E4-1BB9-4DC0-A264-C726C6903DA5Q34463422-4A2BF090-1869-4B96-9F38-988869276B97Q34494754-3B455709-82D5-4A87-9E47-BA04EA8F32BDQ34611946-57F44153-2E32-4558-9A64-A8798A85CC95Q42136589-7BD500CE-F6F4-4D51-8064-555764DBB387Q43854286-50F61769-C209-458C-9D94-78AE52457096Q46113385-98EDA972-54C2-4AF7-9C59-A7F61893041DQ46643788-7FF2EB7D-BB0E-462A-A229-18031F0A8B03Q47345068-D16D3F16-D3FC-4998-B3E1-C97960250012Q47399326-37C43670-154D-40A6-9E01-90B38A104172Q47661500-5C192ECC-91C1-40FB-A2B1-553052CF2F6FQ48020961-32EE5381-D395-4856-BC90-731BDFE3A0ACQ50541070-41A1B316-741D-485B-9CA3-5304B3523868Q50923686-79936F6B-95A0-43BB-9B6C-3B10186178C0Q51755687-40035FC5-92C4-44FF-B39A-9133BC54082BQ51836070-1BE97DD5-F8E4-4D91-B9C4-BBD3C0CF0BB2Q52296539-B435E441-3C5D-4B83-82EC-C0332076AAE6Q54322716-06E28284-C541-4D65-9DF1-0936B69E752DQ82895305-A467AB06-9D75-4549-A6FC-878FBF29D021Q83514439-CE09FFD2-3234-4E71-B9A0-22D918A1A5F3Q84295254-DC3E2929-18A5-499E-B897-8FED13822C62Q86289808-52467F98-FFA3-4F8F-B656-72971C5FA667Q90416733-1ABF7106-739B-4532-8C7A-6AE934B92A4E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jean-Benoit Hardouin
@ast
Jean-Benoit Hardouin
@en
Jean-Benoit Hardouin
@es
Jean-Benoit Hardouin
@nl
Jean-Benoit Hardouin
@sl
type
label
Jean-Benoit Hardouin
@ast
Jean-Benoit Hardouin
@en
Jean-Benoit Hardouin
@es
Jean-Benoit Hardouin
@nl
Jean-Benoit Hardouin
@sl
prefLabel
Jean-Benoit Hardouin
@ast
Jean-Benoit Hardouin
@en
Jean-Benoit Hardouin
@es
Jean-Benoit Hardouin
@nl
Jean-Benoit Hardouin
@sl
P106
P1153
22957797200
P21
P31
P496
0000-0001-8664-623X